Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines
Clinical trial NCT00512135 · COMPLETED
Trial details
- NCT number
- NCT00512135
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-18
- Primary completion
- 2009-12-28
- Enrollment
- 801
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.